Trial Details

COMPLETED
Basic Information
Clinical ID c601
Identifier NCT00261118
Trial Title Rituximab in Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Rituximab
Participant Information
Sponsor Royal Liverpool University Hospital
City Liverpool
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2025-04-04
Primary Completion Date 2025-08-09
Completion Date 2025-10-09